Riggs Asset Managment Co. Inc. Virax Biolabs Group LTD Transaction History

Riggs Asset Managment Co. Inc.

  • $358 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
BUY
$2.47 - $32.9 $9 - $131
4 New
4 $0

About Virax Biolabs Group Ltd

VRAX Quotes by TradingView
  • Ticker VRAX
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,374,100
  • Market Cap $22.4M
  • Description
  • Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid te...
More about VRAX
Track This Portfolio

Track Riggs Asset Managment Co. Inc. Portfolio

Follow Riggs Asset Managment Co. Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riggs Asset Managment Co. Inc., based on Form 13F filings with the SEC.

News

Stay updated on Riggs Asset Managment Co. Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email